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Vitamin D is recognized to have important actions
outside its well-recognized role in musculoskeletal
health. These include antimicrobial action, anti-
inflammatory, and cardio-protective properties. A high
prevalence of vitamin D deficiency and its association
with adverse clinical outcomes have now been widely
documented in observational studies in the critically ill.
These studies of association, however, do not
necessarily imply causation, as vitamin D deficiency
may be merely a marker of higher illness severity and
consequently poorer outcomes. This issue can be
clarified only by undertaking high-quality randomized
controlled trials of vitamin D supplementation in this
vulnerable population.may be important for circulating 1,25-dihydroxy-D3Introduction
In the previous issue of Critical Care, Amrein and col-
leagues [1] report a single-center observational study of
655 surgical and non-surgical critically ill patients over a
2-year period and describe the association between vita-
min D status and seasonality and mortality in critical ill-
ness. Vitamin D, traditionally considered important for
the maintenance of calcium homeostasis and musculo-
skeletal health, is now widely recognized for its extra-
skeletal ‘pleiotropic effects’. Over the past decade, data
from biochemical and molecular genetic studies indicate
that vitamin D - particularly its active form, 1,25-dihy-
droxy cholecalciferol (1,25-dihydroxy-D3) - has a much
wider role. These pleiotropic effects include potentiation
of antimicrobial action and cardio-protective and immu-
nomodulatory effects. The discoveries that most tissues* Correspondence: bala.venkatesh@health.qld.gov.au
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2014and cells in the body have vitamin D receptors and that
several possess the 1-α hydroxylase enzyme have pro-
vided novel insights into the pleiotropic actions of this
vitamin [2].
Hypovitaminosis D: Prevalence and associations
with clinical outcome
Vitamin D is synthesized in the skin and then undergoes
25-hydroxylation in the liver to 25-hydroxy-D3 followed
by 1α-hydroxylation, especially but not exclusively in the
kidneys, to 1,25-dihydroxy-D3. Based on optimal bone
health, a widely used definition considers a serum 25-
hydroxy-D3 of less than 20 ng/mL (50 nmol/L) to be a
vitamin D deficiency, 20 to 30 ng/mL (50 to 75 nmol/L)
to be insufficient, and more than 30 ng/mL (75 nmol/L)
to be normal. Although renal 1α-hydroxylase activation
levels, locally 1,25-dihydroxy-D3 formed by tissue 1α-
hydroxylase is critical in mediating the pleiotropic ac-
tions of vitamin D. Vitamin D sufficiency is required for
both the endocrine and paracrine arms of the axis to
function effectively.
There is increasing evidence that vitamin D deficiency is
common in hospitalized patients and particularly in the
critically ill. Hypovitaminosis D has been associated with
increased incidence of a number of autoimmune condi-
tions and adverse outcomes in cardiac transplant recipi-
ents and the general population [3]. Although vitamin D
insufficiency does not pose immediate health hazards in
otherwise healthy individuals, it may be detrimental dur-
ing critical illness, as the circulating vitamin D pool func-
tions as an important reservoir for local conversion to the
active metabolites at tissue level during stress [4].
Global interest in the significance of vitamin D defi-
ciency in critical illness was triggered in 2009 following
a report by Lee and colleagues [5], who noted a previ-
ously under-recognized high prevalence of hypovitami-
nosis D. Only 7 % of patients were vitamin D-sufficient,
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critically ill patients have reported a prevalence ranging
from 38 % to 100 %, which is about 50 % higher than
that for patients in general medical wards.
Several observational studies in critically ill patients have
also demonstrated an association between vitamin D defi-
ciency/insufficiency and poor outcomes. These include in-
creases in illness severity and risk of death, ICU length of
stay [6-8], ventilator requirement [9], rates of infection
(including ventilator-associated pneumonia) [10], blood
culture positivity [11], organ dysfunction, and short-term
and long-term hospital mortality [5,9,11]. Furthermore,
ICU and hospital costs were found to be higher for vita-
min D-deficient patients.
In this context, the study findings of Amrein and col-
leagues are in accord with previously published data. Vita-
min D levels were categorized by month-specific tertiles
(high, intermediate, and low) to reflect seasonal variation
of serum 25-hydroxy-D3 levels. There was a high preva-
lence of vitamin D deficiency and insufficiency. Adjusted
hospital mortality was significantly higher in patients in
the low and intermediate compared with those in the high
tertiles. No sepsis-related fatality was observed in the
highest month-specific tertile or in vitamin D sufficiency.
The authors concluded that low 25-hydroxy-D3 status is
significantly associated with all-cause and sepsis mortality
in the critically ill and suggested that interventional stud-
ies are warranted to study the effect of vitamin D supple-
mentation on outcome in this population. However, the
indications for vitamin D assays in these patients were un-
clear; it was a convenience sample resulting in a selection
bias as only patients who had vitamin D assays performed
were chosen. There were no differences in bacteremia be-
tween survivors and non-survivors. Data on inflammatory
markers were not reported. Moreover, vitamin D levels
are influenced by fluid shifts and diurnal variability,
throwing into doubt the significance of a single measure-
ment [12,13].
Despite these limitations, the study adds to the bur-
geoning volume of literature on the prevalence of hypo-
vitaminosis D in critically ill patients and the resulting
potential for adverse outcomes. Where do we go from
here? There have been calls for universal vitamin D sup-
plementation in critically ill patients. Given the present
evidence, this would be premature as a number of ca-
veats still remain.
The criteria for definitions of vitamin D sufficiency are
based on bone health; the optimal level for pleiotropy re-
mains unclear. Moreover, little data exist on the bio-
active form, 1,25-dihydroxy-D3, in critical illness and as-
sociation with outcomes. Reports of supra-physiological
levels of 1,25-dihydroxy-D3 following inflammatory re-
sponse in critically ill patients [12] and, more recently,
evidence of extra-renal production of 1,25-dihydroxy-D3[14] have been published. Furthermore, the high degree
of protein binding of 25-hydroxy-D3 and consequently
the relevance of free levels, particularly in the context of
altered pharmacokinetics associated with critical illness,
remain to be elucidated.
Conclusions
The observational studies available do not suggest caus-
ation, and hypovitaminosis D may be simply a marker of
poor health, which predicts patients who would have
poorer outcomes. Reports that supra-physiological levels
of 25-hydroxy-D3 may be associated with adverse out-
comes are also emerging [15]. The only means to clarify
the role for supplementation is to conduct appropriate
dose-response studies followed by a high-quality placebo-
controlled randomized trial of vitamin D supplementation
in this vulnerable population. Vitamin D is inexpensive
and, if it is shown to be beneficial, there is no barrier
to rapid implementation into routine clinical practice
worldwide.
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